Amundi Simulations Plus, Inc. Transaction History
Amundi
- $264 Billion
- Q3 2024
A detailed history of Amundi transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Amundi holds 932 shares of SLP stock, worth $26,422. This represents 0.0% of its overall portfolio holdings.
Number of Shares
932
Previous 932
-0.0%
Holding current value
$26,422
Previous $45,000
35.56%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SLP
# of Institutions
175Shares Held
15.1MCall Options Held
5.4KPut Options Held
1.4K-
Black Rock Inc. New York, NY2.46MShares$69.9 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC1.94MShares$54.9 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$32.6 Million0.0% of portfolio
-
Ranger Investment Management, L.P. Dallas, TX902KShares$25.6 Million1.9% of portfolio
-
State Street Corp Boston, MA640KShares$18.2 Million0.0% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $575M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...